Stockreport

Kadmon Announces Data Demonstrating the Potential of the Company’s New GLUT Inhibitors for the Treatment of Autoimmune and Inflammatory Conditions

Kadmon Holdings, Inc.  (KDMN) 
Last kadmon holdings, inc. earnings: 3/5 04:14 pm Check Earnings Report
US:NYSE Investor Relations: investors.kadmon.com
PDF -- Preclinical Data to be Presented at Keystone Symposia on Integrating Metabolism and Immunity -- NEW YORK--(BUSINESS WIRE)-- Kadmon Holdings [Read more]